Comparison

Neuroscience

365 Item(s)

per page

Name PDF Type Clone Specific against Appl. Host Item no. Amount Price
Amgen patent anti-­beta amyloid Biosimilar(Anti-­Amyloid Beta Reference Antibody ) Other DCC-A672-5mg

DCChemicals
5 mg Login
Compare
Abrilumab Biosimilar(Anti-­Integrin a4b7 (ITGA4 & ITGB7) Reference Antibody) Other DCC-A097-100mg

DCChemicals
100 mg Login
Compare
lendalizumab Biosimilar (Anti-­Complement C5 Reference Antibody) Other DCC-A071-100mg

DCChemicals
100 mg Login
Compare
lendalizumab Biosimilar (Anti-­Complement C5 Reference Antibody) Other DCC-A071-1mg

DCChemicals
1 mg Login
Compare
lendalizumab Biosimilar (Anti-­Complement C5 Reference Antibody) Other DCC-A071-5mg

DCChemicals
5 mg Login
Compare
UCB patent anti-­Gremlin-­1 Biosimilar (Anti-­GREM1 /­ Gremlin Reference Antibody) Other DCC-A160-100mg

DCChemicals
100 mg Login
Compare
Codrituzumab-­MMAE Biosimilar(Anti-­GPC3 /­ Glypican-­3 Reference Antibody) Other DCC-A152-100mg

DCChemicals
100 mg Login
Compare
Codrituzumab Biosimilar(Anti-­GPC3 /­ Glypican-­3 Reference Antibody) Other DCC-A151-100mg

DCChemicals
100 mg Login
Compare
Minomic patent anti-­Glypican 1 Biosimilar(Anti-­GPC1 /­ Glypican-­1 Reference Antibody) Other DCC-A149-100mg

DCChemicals
100 mg Login
Compare
SC-­005 Biosimilar(Anti-­Melanotransferrin /­ CD228 Reference Antibody) Other DCC-A339-100mg

DCChemicals
100 mg Login
Compare
SC-­005 Biosimilar(Anti-­Melanotransferrin /­ CD228 Reference Antibody) Other DCC-A339-1mg

DCChemicals
1 mg Login
Compare
SC-­005 Biosimilar(Anti-­Melanotransferrin /­ CD228 Reference Antibody) Other DCC-A339-5mg

DCChemicals
5 mg Login
Compare
BMS patent anti-­Integrin α5β1 Biosimilar(Anti-­Integrin a5b1 (ITGA5 & ITGB1) Reference Antibody) Other DCC-A293-100mg

DCChemicals
100 mg Login
Compare
Etrolizumab Biosimilar(Anti-­Integrin a4b7 (ITGA4 & ITGB7) Reference Antibody) Other ELISA, other DCC-A289-100mg

DCChemicals
100 mg Login
Compare
Garetosmab Biosimilar(Anti-­INHBA /­ Activin A Reference Antibody) Other DCC-A286-100mg

DCChemicals
100 mg Login
Compare
Minomic patent anti-­Glypican 1 Biosimilar(Anti-­GPC1 /­ Glypican-­1 Reference Antibody) Other DCC-A149-1mg

DCChemicals
1 mg Login
Compare
Minomic patent anti-­Glypican 1 Biosimilar(Anti-­GPC1 /­ Glypican-­1 Reference Antibody) Other DCC-A149-5mg

DCChemicals
5 mg Login
Compare
Codrituzumab Biosimilar(Anti-­GPC3 /­ Glypican-­3 Reference Antibody) Other DCC-A151-1mg

DCChemicals
1 mg Login
Compare
Codrituzumab Biosimilar(Anti-­GPC3 /­ Glypican-­3 Reference Antibody) Other DCC-A151-5mg

DCChemicals
5 mg Login
Compare
Codrituzumab-­MMAE Biosimilar(Anti-­GPC3 /­ Glypican-­3 Reference Antibody) Other DCC-A152-1mg

DCChemicals
1 mg Login
Compare
Codrituzumab-­MMAE Biosimilar(Anti-­GPC3 /­ Glypican-­3 Reference Antibody) Other DCC-A152-5mg

DCChemicals
5 mg Login
Compare
UCB patent anti-­Gremlin-­1 Biosimilar (Anti-­GREM1 /­ Gremlin Reference Antibody) Other DCC-A160-1mg

DCChemicals
1 mg Login
Compare
UCB patent anti-­Gremlin-­1 Biosimilar (Anti-­GREM1 /­ Gremlin Reference Antibody) Other DCC-A160-5mg

DCChemicals
5 mg Login
Compare
Volociximab Biosimilar(Anti-­Integrin a5b1 (ITGA5 & ITGB1) Reference Antibody) Other DCC-A949-100mg

DCChemicals
100 mg Login
Compare
Crizanlizumab Biosimilar(Anti-­P-­Selectin /­ CD62p Reference Antibody) Other DCC-A943-100mg

DCChemicals
100 mg Login
Compare
Name Price
Amgen patent anti-­beta amyloid Biosimilar(Anti-­Amyloid Beta Reference Antibody ) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 5 mg
Available
Abrilumab Biosimilar(Anti-­Integrin a4b7 (ITGA4 & ITGB7) Reference Antibody) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 100 mg
Available
lendalizumab Biosimilar (Anti-­Complement C5 Reference Antibody) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 100 mg
Available
lendalizumab Biosimilar (Anti-­Complement C5 Reference Antibody) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 1 mg
Available
lendalizumab Biosimilar (Anti-­Complement C5 Reference Antibody) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 5 mg
Available
UCB patent anti-­Gremlin-­1 Biosimilar (Anti-­GREM1 /­ Gremlin Reference Antibody) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 100 mg
Available
Codrituzumab-­MMAE Biosimilar(Anti-­GPC3 /­ Glypican-­3 Reference Antibody) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 100 mg
Available
Codrituzumab Biosimilar(Anti-­GPC3 /­ Glypican-­3 Reference Antibody) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 100 mg
Available
Minomic patent anti-­Glypican 1 Biosimilar(Anti-­GPC1 /­ Glypican-­1 Reference Antibody) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 100 mg
Available
SC-­005 Biosimilar(Anti-­Melanotransferrin /­ CD228 Reference Antibody) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 100 mg
Available
SC-­005 Biosimilar(Anti-­Melanotransferrin /­ CD228 Reference Antibody) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 1 mg
Available
SC-­005 Biosimilar(Anti-­Melanotransferrin /­ CD228 Reference Antibody) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 5 mg
Available
BMS patent anti-­Integrin α5β1 Biosimilar(Anti-­Integrin a5b1 (ITGA5 & ITGB1) Reference Antibody) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 100 mg
Available
Etrolizumab Biosimilar(Anti-­Integrin a4b7 (ITGA4 & ITGB7) Reference Antibody) Login
Type
Clone
Specific against Other
Appl. ELISA, other
Host
Item no.
Amount 100 mg
Available
Garetosmab Biosimilar(Anti-­INHBA /­ Activin A Reference Antibody) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 100 mg
Available
Minomic patent anti-­Glypican 1 Biosimilar(Anti-­GPC1 /­ Glypican-­1 Reference Antibody) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 1 mg
Available
Minomic patent anti-­Glypican 1 Biosimilar(Anti-­GPC1 /­ Glypican-­1 Reference Antibody) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 5 mg
Available
Codrituzumab Biosimilar(Anti-­GPC3 /­ Glypican-­3 Reference Antibody) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 1 mg
Available
Codrituzumab Biosimilar(Anti-­GPC3 /­ Glypican-­3 Reference Antibody) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 5 mg
Available
Codrituzumab-­MMAE Biosimilar(Anti-­GPC3 /­ Glypican-­3 Reference Antibody) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 1 mg
Available
Codrituzumab-­MMAE Biosimilar(Anti-­GPC3 /­ Glypican-­3 Reference Antibody) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 5 mg
Available
UCB patent anti-­Gremlin-­1 Biosimilar (Anti-­GREM1 /­ Gremlin Reference Antibody) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 1 mg
Available
UCB patent anti-­Gremlin-­1 Biosimilar (Anti-­GREM1 /­ Gremlin Reference Antibody) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 5 mg
Available
Volociximab Biosimilar(Anti-­Integrin a5b1 (ITGA5 & ITGB1) Reference Antibody) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 100 mg
Available
Crizanlizumab Biosimilar(Anti-­P-­Selectin /­ CD62p Reference Antibody) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 100 mg
Available

365 Item(s)

per page